Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 5, 2011.
Copyright & Usage
© PDA, Inc. 2011
Author Information
- 1Torbeck and Assoc., Evanston, IL;
- 2FDA/CDER/DMPQ/Microbiologist, Silver Spring, MD;
- 3U.S. Food and Drug Administration, Northeast Regional Laboratory, Jamaica, NY;
- 4CDER/US FDA, Silver Spring, MD; and
- 5Office of Pharmaceutical Science/CDER/US FDA, Silver Spring, MD
- ↵* Correspondence author: Division of Manufacturing and Product Quality, CDER/US FDA, 10903 New Hampshire Ave., Silver Spring, MD 20903. E-mail: Rick.Friedman{at}fda.hhs.gov
Cited By...
Burkholderia cepacia: This Decision Is Overdue
Jump to section
Related Articles
Cited By...
- Mapping the Efficacy and Mode of Action of Ethylzingerone [4-(3-Ethoxy-4-Hydroxyphenyl) Butan-2-One] as an Active Agent against Burkholderia Bacteria
- Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products
- Real-Time PCR Detection of Burkholderia cepacia in Pharmaceutical Products Contaminated with Low Levels of Bacterial Contamination
- Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride
- Draft Genome Sequences of Burkholderia contaminans FFI-28, a Strain Isolated from a Contaminated Pharmaceutical Solution
- Direct Detection of Burkholderia cepacia in Susceptible Pharmaceutical Products Using Semi-Nested PCR
- Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients
- Postoperative endophthalmitis due to Burkholderia cepacia complex from contaminated anaesthetic eye drops
- Key Role for Efflux in the Preservative Susceptibility and Adaptive Resistance of Burkholderia cepacia Complex Bacteria
More in this TOC Section
Similar Articles